HIV drug cocktail approved for HIV prevention in US, as world turns its attention to Washington DC for global AIDS conference
- Created on Jul 20, 2012
Preparations for the upcoming XIX International AIDS Conference in Washington DC, USA were given a boost this week by the announcement by the US Food and Drug Administration (FDA) that it has approved a combination of antiretroviral drugs for use in HIV prevention. Truvada® (emtricitabine/tenofovir disoproxil fumarate) can now be used by adults who have not been infected with HIV but are at risk of contracting the disease.
"This is great news," said Ben Plumley, Chief Executive Officer of Pangaea. "It is no magic bullet, but is further evidence of a promising new HIV prevention approach, pre-exposure prophylaxis (PrEP). The challenge now is to ensure it is accessible and affordable, as part of a platform of services, to those all who need it most, especially in marginalized communities. "
The role of PrEP will be one of the key issues raised at the XIX International AIDS Conference, which opens on 22nd of July. It is the first major international AIDS conference to be held after the US dropped in 2010 its discriminatory ban on people with HIV entering the country. Up to 30,000 people from around the world will congregate in Washington DC to share the latest information on the AIDS epidemic, one of the greatest social and medical challenges facing the world.
Newly appointed Pangaea Managing Director, Ben Cheng said, "In the last decade, we have seen significant progress in the number of people living with HIV accessing life-saving medicines. However, these gains will be short-lived if we do not sustain global funding, expanded access to services and continued research and development into new medicines. These are priorities that must be raised at Washington."
David Barr, Senior Pangaea Consultant, added, "While communities of people with HIV are now widely understood to have played pivotal roles in mobilizing access to treatment, funding for these groups is under threat, as national and international HIV budgets are cut. Investing in communities saves lives and is the foundation for the long-term response to this epidemic."
Pangaea has a full calendar of activities at the Washington, DC International AIDS Conference, and will be providing regular updates which can be found here on our newly-updated website
Pangaea is a non-profit international organization committed to building partnerships to improve the lives of people living with and most at-risk of HIV, regardless of where they live, to ensure equitable access to prevention, testing, treatment and care.